Your browser doesn't support javascript.
loading
Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
Mørk, Sofie Kirial; Kadivar, Mohammad; Bol, Kalijn Fredrike; Draghi, Arianna; Westergaard, Marie Christine Wulff; Skadborg, Signe Koggersbøl; Overgaard, Nana; Sørensen, Anders Bundgård; Rasmussen, Ida Svahn; Andreasen, Lars Vibe; Yde, Christina Westmose; Trolle, Thomas; Garde, Christian; Friis-Nielsen, Jens; Nørgaard, Nis; Christensen, Dennis; Kringelum, Jens Vindahl; Donia, Marco; Hadrup, Sine Reker; Svane, Inge Marie.
Afiliación
  • Mørk SK; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Kadivar M; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.
  • Bol KF; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Draghi A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Westergaard MCW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Skadborg SK; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.
  • Overgaard N; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.
  • Sørensen AB; Evaxion Biotech A/S, Denmark.
  • Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Yde CW; Diagnostic Center Rigshospitalet, Genomic Medicine Rigshospitalet, Copenhagen, Denmark.
  • Trolle T; Evaxion Biotech A/S, Denmark.
  • Garde C; Evaxion Biotech A/S, Denmark.
  • Friis-Nielsen J; Evaxion Biotech A/S, Denmark.
  • Nørgaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark.
  • Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
  • Kringelum JV; Evaxion Biotech A/S, Denmark.
  • Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Hadrup SR; Department of Health Technology, Technical University of Denmark- DTU, HEALTH TECH, Lyngby, Denmark.
  • Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Oncoimmunology ; 11(1): 2023255, 2022.
Article en En | MEDLINE | ID: mdl-35036074
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Melanoma Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Melanoma Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article